Company intelligence / Profile preview

MedAi

Ownership: Private
Development stage: Preclinical

Overview

MedAi has launched a commercial AI-powered digital health platform providing remote access to personalized healthcare services. The company is running pilot programs in Bangladesh with research collaborations involving medical colleges and private clinics. Its solutions include telemedicine apps, intelligent EHR modules for clinical insights, analytics for policymakers/providers, and cloud-based patient data management[1][2][4][5].

Therapeutic areas: Other
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Partnerships

Research collaboration with a medical college and four private clinics in rural Bangladesh[4]

Beyond the preview

Go deeper on MedAi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedAi.

Explore the full profile